Udit Verma

3.4k total citations
63 papers, 2.4k citations indexed

About

Udit Verma is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Udit Verma has authored 63 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 19 papers in Molecular Biology and 17 papers in Cancer Research. Recurrent topics in Udit Verma's work include Colorectal Cancer Treatments and Studies (15 papers), NF-κB Signaling Pathways (11 papers) and Cancer Treatment and Pharmacology (9 papers). Udit Verma is often cited by papers focused on Colorectal Cancer Treatments and Studies (15 papers), NF-κB Signaling Pathways (11 papers) and Cancer Treatment and Pharmacology (9 papers). Udit Verma collaborates with scholars based in United States, Spain and Italy. Udit Verma's co-authors include Richard B. Gaynor, Yumi Yamamoto, Shashi Prajapati, Youn-Tae Kwak, Carlos Becerra, Rama Mohan Surabhi, Eugene P. Frenkel, Carmela Lamberti, Youn Tae Kwak and Al B. Benson and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Udit Verma

62 papers receiving 2.4k citations

Peers

Countries citing papers authored by Udit Verma

Since Specialization

Citations

This map shows the geographic impact of Udit Verma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Udit Verma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Udit Verma more than expected).

Fields of papers citing papers by Udit Verma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Udit Verma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Udit Verma. The network helps show where Udit Verma may publish in the future.

Co-authorship network of co-authors of Udit Verma

This figure shows the co-authorship network connecting the top 25 collaborators of Udit Verma. A scholar is included among the top collaborators of Udit Verma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Udit Verma. Udit Verma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Disparities in Characteristics, Access to Care, and Oncologic Outcomes in Young-Onset Colorectal Cancer at a Safety-Net Hospital 2021 ·JCO Oncology Practice ·(unknown), (unknown), (unknown), Muhammad Shaalan Beg, Nina N. Sanford, Aravind Sanjeevaiah, John V. Cox, Michael R. Folkert, Todd A. Aguilera, (unknown), (unknown), Gaurav Khatri, Craig Olson, Patricio M. Polanco, Udit Verma, David Hsiehchen, (unknown), Radhika Kainthla, Syed Mohammad Ali Kazmi	3
2	Racial/Ethnic Disparities and Survival Characteristics in Non-Pancreatic Gastrointestinal Tract Neuroendocrine Tumors 2020 ·Cancers ·(unknown), Muhammet Özer, Muhammad Shaalan Beg, Nina N. Sanford, Chul Ahn, (unknown), (unknown), Udit Verma, Aravind Sanjeevaiah, David Hsiehchen, Amy Jones, Radhika Kainthla, Syed Mohammad Ali Kazmi	5
3	Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution 2019 ·JCI Insight ·Abdel Hosein, Huocong Huang, Zhaoning Wang, Kamalpreet Parmar, Wenting Du, Jonathan Huang, Anirban Maitra, Eric N. Olson, Udit Verma, Rolf A. Brekken	188
4	Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the In Vitro Integrity of T Cells from Cancer Patients 2018 ·Clinical Cancer Research ·Masato Kobayashi, Jin-Sung Chung, Muhammad Shaalan Beg, Yull Arriaga, Udit Verma, Kevin D. Courtney, John C. Mansour, Barbara Haley, Saad A. Khan, Yutaka Horiuchi, Vijay Ramani, David Harker, Purva Gopal, (unknown), Ponciano D. Cruz, Kiyoshi Ariizumi	46
5	Fasting and Glucose-Stimulated Changes in Plasma Glucagon in Pancreatic Cancer 2018 ·Pancreas ·Jennifer H. Stern, Yull Arriaga, Arjun Gupta, Udit Verma, (unknown), Samira Syed, (unknown), John C. Mansour, (unknown), Philipp E. Scherer, Muhammad Shaalan Beg	3
6	A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer 2017 ·Annals of Oncology ·Jaffer A. Ajani, Mikhail Abramov, Igor Bondarenko, (unknown), В. А. Горбунова, (unknown), (unknown), María Alsina, Sergey Lazarev, Jaime Feliú, Anneli Elme, (unknown), Kathia Cristina Abdalla, Udit Verma, Fabio Benedetti, (unknown), Hirokazu Mizuguchi, Lukas Makris, Gerardo Rosati	37
7	Subgroup analysis of patients with metastatic colorectal cancer (mCRC) treated with regorafenib (REG) in the phase 3b CONSIGN trial who had progression-free survival (PFS) >4 months (m) 2016 ·Annals of Oncology ·Rocio García‐Carbonero, Eric Van Cutsem, Fortunato Ciardiello, Marc Ychou, J.F. Seitz, (unknown), Yull Arriaga, Udit Verma, Axel Grothey, (unknown), J. Kalmus, Christian Kappeler, Alfredo Falcone, Alberto Zaniboni	5
8	140O Results from the large, open-label phase 3b CONSIGN study of regorafenib in patients with previously treated metastatic colorectal cancer (mCRC) 2015 ·Annals of Oncology ·Eric Van Cutsem, Fortunato Ciardiello, Jean‐François Seitz, Ralf‐Dieter Hofheinz, Udit Verma, Rocio García‐Carbonero, Axel Grothey, (unknown), J. Kalmus, (unknown), Alfredo Falcone, Alberto Zaniboni	15
9	Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5‐fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204 2013 ·Cancer ·Jerome C. Landry, Yang Feng, Steven J. Cohen, Charles A. Staley, Richard Whittington, Elin R. Sigurdson, Halla Nimeiri, Udit Verma, Roshan S. Prabhu, Al B. Benson	41
10	Shorter bevacizumab infusions do not increase the incidence of proteinuria and hypertension 2012 ·Annals of Oncology ·(unknown), (unknown), Jonathan E. Dowell, Eileen M. Marley, (unknown), Yull Arriaga, Udit Verma	12
11	Soluble and insoluble nickel compounds exert a differential inhibitory effect on cell growth through IKKα‐dependent cyclin D1 down‐regulation 2008 ·Journal of Cellular Physiology ·Weiming Ouyang, Dongyun Zhang, Jingxia Li, Udit Verma, Max Costa, Chuanshu Huang	25
12	Efficacy of sequential treatment of HCT116 colon cancer monolayers and xenografts with docetaxel, flavopiridol, and 5-fluorouracil 2006 ·Acta Pharmacologica Sinica ·Jun Guo, Anwu Zhou, Yu‐Cai Fu, Udit Verma, Debu Tripathy, (unknown), Carlos Becerra	26
13	IκB Kinase α Regulates Subcellular Distribution and Turnover of Cyclin D1 by Phosphorylation 2005 ·Journal of Biological Chemistry ·Youn Tae Kwak, Rui Li, Carlos Becerra, Debu Tripathy, Eugene P. Frenkel, Udit Verma	56
14	Protein Phosphatase 2Cβ Association with the IκB Kinase Complex Is Involved in Regulating NF-κB Activity 2004 ·Journal of Biological Chemistry ·Shashi Prajapati, Udit Verma, Yumi Yamamoto, Youn Tae Kwak, Richard B. Gaynor	73
15	IKKα Regulates Mitogenic Signaling through Transcriptional Induction of Cyclin D1 via Tcf 2003 ·Molecular Biology of the Cell ·Chris Albanese, Kongming Wu, Mark D’Amico, (unknown), David A. Joyce, (unknown), James Hulit, Toshiyuki Sakamaki, Maofu Fu, Avri Ben‐Ze'ev, Jacqueline Bromberg, Carmela Lamberti, Udit Verma, Richard B. Gaynor, Stephen W. Byers, Richard G. Pestell	131
16	IKKγ/NEMO Facilitates the Recruitment of the IκB Proteins into the IκB Kinase Complex 2001 ·Journal of Biological Chemistry ·Yumi Yamamoto, Dong‐Wan Kim, Youn-Tae Kwak, Shashi Prajapati, Udit Verma, Richard B. Gaynor	47
17	Regulation of β-Catenin Function by the IκB Kinases 2001 ·Journal of Biological Chemistry ·Carmela Lamberti, Keng Lin, Yumi Yamamoto, Udit Verma, Inder M. Verma, Steven S. Byers, Richard B. Gaynor	123
18	Post-bone marrow transplant use of immunotherapy 1997 ·Cancer treatment and research ·Udit Verma, Kenneth R. Meehan, A Mazumder	4
19	Immunomodulation following chemotherapy 1996 ·Breast Cancer Research and Treatment ·(unknown), Udit Verma, M. Hawkins, A Mazumder	2
20	Interleukin-2 in Bone Marrow Transplantation 1995 ·Cancer treatment and research ·Udit Verma, Bishan S. Charak, Chitra Rajagopal, (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact